WANY
BSX icon

Wealthspire Advisors (New York)’s Boston Scientific BSX Stock Holding History

Wealthspire Advisors (New York)’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$362K Sell
5,765
-7,894
-58% -$632K ﹤0.01% 676
2025
Q4 		$1.3M Buy
13,659
+7,829
+134% +$768K 0.01% 373
2025
Q3 		$569K Sell
5,830
-1,096
-16% -$114K ﹤0.01% 504
2025
Q2 		$744K Buy
6,926
+719
+12% +$72.8K ﹤0.01% 443
2025
Q1 		$626K Buy
6,207
+198
+3% +$19.9K ﹤0.01% 467
2024
Q4 		$537K Buy
6,009
+1,773
+42% +$156K 0.01% 496
2024
Q3 		$355K Buy
4,236
+410
+11% +$32.3K ﹤0.01% 581
2024
Q2 		$295K Buy
3,826
+80
+2% +$5.86K ﹤0.01% 546
2024
Q1 		$257K Sell
3,746
-1,021
-21% -$65.6K ﹤0.01% 549
2023
Q4 		$276K Buy
4,767
+942
+25% +$50.3K ﹤0.01% 542
2023
Q3 		$202K Buy
+3,825
New +$201K ﹤0.01% 563
2023
Q2 		– Sell
-4,033
Closed -$202K – 563
2023
Q1 		$202K Sell
4,033
-3,674
-48% -$173K ﹤0.01% 506
2022
Q4 		$357K Buy
+7,707
New +$334K 0.01% 423
2022
Q1 		– Sell
-6,159
Closed -$262K – 447
2021
Q4 		$262K Buy
6,159
+699
+13% +$29.4K 0.01% 451
2021
Q3 		$237K Buy
+5,460
New +$242K ﹤0.01% 509
2021
Q2 		– Sell
-18,501
Closed -$715K – 412
2021
Q1 		$715K Buy
18,501
+4,016
+28% +$152K 0.02% 321
2020
Q4 		$521K Buy
14,485
+4,436
+44% +$160K 0.02% 299
2020
Q3 		$384K Buy
10,049
+1,774
+21% +$68.4K 0.02% 204
2020
Q2 		$291K Sell
8,275
-5,192
-39% -$187K 0.02% 210
2020
Q1 		$439K Buy
+13,467
New +$526K 0.02% 314
2019
Q1 		– Sell
-1,051
Closed -$37K – 153
2018
Q4 		$37K Buy
+1,051
New +$38.1K ﹤0.01% 224

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wealthspire Advisors (New York)'s BSX Position: Q1 2026 in Review

Wealthspire Advisors (New York) reduced its Boston Scientific (BSX) stake by 58% in Q1 2026, selling an estimated $632K and leaving 5,765 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #676.

Wealthspire Advisors (New York) first reported a position in BSX in Q4 2018 and has held it in 21 quarters since. The position peaked at $1.3M in Q4 2025. 1,668 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Wealthspire Advisors (New York) held 5,765 shares of Boston Scientific worth $362K as of Q1 2026.
  • Wealthspire Advisors (New York) sold 7,894 Boston Scientific shares in Q1 2026, an estimated $632K.
  • Boston Scientific made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q1 2026, its #676 holding.
  • Wealthspire Advisors (New York) first reported a position in Boston Scientific in Q4 2018 and has held it in 21 quarters since.
  • Wealthspire Advisors (New York)'s Boston Scientific position peaked at $1.3M in Q4 2025.
  • 1,668 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.